Dr. Athanasios Smyrlis, MD

Dr. Smyrlis practices at Mount Sinai South Nassau in Oceanside, New York, part of Mount Sinai Health System.

Dr. Smyrlis' NPI, 1871721175, was assigned on June 24, 2009. Dr. Smyrlis graduated from University of Ioannina Faculty of Medicine in 2007. Dr. Smyrlis holds New York license 284254.

Dr. Smyrlis' primary practice is Mount Sinai South Nassau, at One Healthy Way, Oceanside, NY 11572 in Nassau County. The practice phone is (516) 632-3000. Dr. Smyrlis also practices at South Nassau Communities Hospital, 1 Healthy Way, Oceanside, NY 11572.

Dr. Smyrlis' primary practice is Mount Sinai South Nassau in Oceanside, New York, part of Mount Sinai Health System. Dr. Smyrlis is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai South Nassau. Dmand AI also links Dr. Smyrlis to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smyrlis practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Smyrlis' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Smyrlis is licensed in New York.

CMS data shows 1,449 Medicare services from Dr. Smyrlis across 13 procedure codes in 2024, for 450 Medicare patients. Medicare paid $142,735 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 450 Medicare patients who saw Dr. Smyrlis in 2024. The largest group is 65 to 74, with 187 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smyrlis' median patient age at 68, with 40% women.

In 2024, Dr. Smyrlis wrote 2,329 Medicare Part D claims for 316 patients. 85% of them were for generic drugs. CMS names the drug for 2,167 of them, across 30 drugs with 11 or more claims each, at $422,340 in total drug cost. In 2023, CMS named 1,642 claims across 28 drugs.

Dr. Smyrlis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 47 procedures of coronary angioplasty and stenting by Dr. Smyrlis, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Smyrlis, published from 2012 to 2015. Dr. Smyrlis' most frequent co-authors are Jongoh Kim, MD, Stefan Valeriu Neagu, MD and William J. Tester, MD.

CMS Open Payments shows 160 general payments to Dr. Smyrlis from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Boston Scientific Corporation paid the most, $2,152.

Dr. Smyrlis graduated from University of Ioannina Faculty of Medicine in 2007.